IRIS
GENTILE, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.836
NA - Nord America 1.520
AS - Asia 1.092
SA - Sud America 475
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.955
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.478
IE - Irlanda 487
IT - Italia 457
BR - Brasile 428
SG - Singapore 426
SE - Svezia 283
HK - Hong Kong 275
CN - Cina 237
DE - Germania 165
PL - Polonia 123
FI - Finlandia 116
IN - India 60
FR - Francia 59
GB - Regno Unito 35
BE - Belgio 19
RU - Federazione Russa 19
NL - Olanda 18
AT - Austria 17
MX - Messico 17
CA - Canada 15
AR - Argentina 14
TR - Turchia 12
BD - Bangladesh 11
UA - Ucraina 11
VN - Vietnam 11
ID - Indonesia 10
EC - Ecuador 9
MA - Marocco 8
VE - Venezuela 8
ZA - Sudafrica 7
CZ - Repubblica Ceca 5
IQ - Iraq 5
JP - Giappone 5
PK - Pakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CO - Colombia 4
KE - Kenya 4
PE - Perù 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
EU - Europa 3
HN - Honduras 3
LT - Lituania 3
NP - Nepal 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
BH - Bahrain 2
BO - Bolivia 2
ES - Italia 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
PY - Paraguay 2
RS - Serbia 2
UG - Uganda 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
OM - Oman 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TG - Togo 1
UY - Uruguay 1
Totale 4.955
Salva come PNG Salva come JPEG
Città #
Dublin 486
Chandler 320
Hong Kong 271
Singapore 269
Nyköping 217
Messina 181
Warsaw 121
Ashburn 116
Munich 109
Beijing 92
Princeton 73
Helsinki 69
Medford 64
The Dalles 56
Ann Arbor 50
Des Moines 47
Jacksonville 37
Pune 29
Wilmington 29
Bremen 24
Dearborn 24
São Paulo 22
Los Angeles 21
Hyderabad 20
Cambridge 19
Turku 18
Belo Horizonte 16
Nuremberg 16
Boardman 15
Brussels 15
Jinan 14
Redwood City 14
Rio de Janeiro 14
Seattle 14
New York 13
Rome 13
Duncan 12
Falls Church 12
Lappeenranta 12
London 11
Palermo 11
Brasília 10
Catania 10
Vienna 10
Zhengzhou 10
Chicago 9
Curitiba 9
Porto Alegre 9
San Francisco 9
Dong Ket 8
Houston 8
Jakarta 8
Ningbo 8
Shenyang 8
Haikou 7
Livorno 7
Milan 7
Nanjing 7
San Mateo 7
Taizhou 7
Changsha 6
Frankfurt am Main 6
Manaus 6
Santa Clara 6
Tianjin 6
Woodbridge 6
Amsterdam 5
Bagheria 5
Brooklyn 5
Collegeville 5
Hangzhou 5
Hebei 5
North Brunswick 5
Padova 5
Piazza Armerina 5
Quito 5
Tashkent 5
Aci Sant'antonio 4
Baghdad 4
Baku 4
Campinas 4
Casablanca 4
Council Bluffs 4
Duque de Caxias 4
Fortaleza 4
Fuzhou 4
Goiânia 4
Governador Valadares 4
Ribeirão Preto 4
San Gregorio di Catania 4
Shanghai 4
Sorocaba 4
Sumaré 4
Taiyuan 4
Tokyo 4
Waanrode 4
Araraquara 3
Betim 3
Bexley 3
Boston 3
Totale 3.323
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 248
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 165
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 144
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 137
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 129
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 129
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 108
A Nouvel serum MicroRNA signature to screen ATTR 93
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 87
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 86
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 85
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 84
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 82
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 82
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 82
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 81
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 81
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 78
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 77
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 74
Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale 72
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 68
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 67
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 67
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 66
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 65
Considerable post-partum worsening in a patient with CMT2E 63
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 62
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 62
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 62
A multicentre study on epidemiology and prevention of needle stick injuries among students of nursing schools 58
"It is not what it seems." Ultrasound findings in a case of unusual iatrogenic ulnar nerve damage. 58
Use of the International Classification of Functioning, Disability and Health Generic-30 Set for the characterization of outpatients: Italian Society of physical and rehabilitative medicine residents section project 58
Early detection of cardiac amyloid deposition in patients with transthyretin-related familial amyloid polyneuropathy by 99mTc-diphosphonate scintigraphy 57
The THAOS: record of patients from our site. 57
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP database 57
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 57
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 56
null 54
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 52
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 52
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 52
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis 51
Early detection of cardiac amyloid deposition in subjects with transthyretin gene mutation by 99mTc-disphosphonate scintigraphy 49
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 49
A Cyst Compressing the Ulnar Nerve Motor Branch: Ultrasonographic Diagnosis of a Tricking Neuropathy. 49
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 48
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 47
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 46
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 46
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 45
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 45
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 44
"Who seeks finds, who compares discovers". Usefulness of ultrasound to assess small nerve branches. 44
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 43
Impact of environmental factors and physical activity on disability and quality of life in CIDP 43
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 43
Use of drugs for ATTRv amyloidosis in the real world: How therapy is changing survival in a non-endemic area 43
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 42
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 42
"Seeing Through the Wall": Ultrasound Application for the Diagnosis and Treatment of Abdominal Pain. 42
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study 40
A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis 39
TTR-FAP: a single-center experience in Sicily, an Italian endemic area 39
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 37
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 37
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 34
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy 34
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients 32
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area 32
Rare among rare: Phenotypes of uncommon CMT genotypes 32
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 32
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early-access program in Italy 32
Ultrasound guidance increases diagnostic yield of needle EMG in plegic muscle. 31
null 30
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 28
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update 28
Shear wave elastography of median nerve at wrist and forearm. Heterogeneity of normative values. 28
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 28
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 27
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 27
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the transthyretin amyloidosis outcomes survey (THAOS) 26
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS 25
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 24
Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy 24
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 23
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 23
null 22
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 21
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 20
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 17
Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease 15
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran 14
Daytime sleepiness and sleep quality in Charcot-Marie-Tooth disease 12
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease 11
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation 10
Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy 8
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? 8
The neurophysiological lesson from the Italian CIDP database 8
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study 6
Totale 5.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.191
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 0 0 0 0 0 0 0 0 0 0 0 60
2020/2021442 21 21 70 21 88 27 42 18 23 74 21 16
2021/2022474 14 48 3 16 40 11 48 28 16 22 31 197
2022/20231.280 106 115 78 76 86 114 19 61 570 13 27 15
2023/2024395 27 56 21 27 32 108 16 32 5 25 6 40
2024/20252.193 72 22 48 142 138 141 202 318 444 124 213 329
Totale 5.280